These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5083614)

  • 1. Acetylcholinesterase. I. A study by nuclear magnetic resonance of the binding of inhibitors to the enzyme.
    Kato G
    Mol Pharmacol; 1972 Sep; 8(5):575-81. PubMed ID: 5083614
    [No Abstract]   [Full Text] [Related]  

  • 2. Acetylcholinesterase. II. A study by nuclear magnetic resonance of the acceleration of acetylcholinesterase by atropine and inhibition by eserine.
    Kato G
    Mol Pharmacol; 1972 Sep; 8(5):582-8. PubMed ID: 5083615
    [No Abstract]   [Full Text] [Related]  

  • 3. Drugs-biomolecule interactions: binding study of substrate and inhibitors to acetylcholinesterase using NMR.
    Kato G
    J Pharm Sci; 1975 Mar; 64(3):488-93. PubMed ID: 1151640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholinesterase. Kinetic studies on the mechanism of atropine inhibition.
    Kato G; Tan E; Yung J
    J Biol Chem; 1972 May; 247(10):3186-9. PubMed ID: 5027748
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of edrophonium, eserine, decamethonium, d-tubocurarine, and gallamine on the kinetics of membrane-bound and solubilized eel acetylcholinesterase.
    Robaire B; Kato G
    Mol Pharmacol; 1975 Nov; 11(6):722-34. PubMed ID: 1207670
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear magnetic resonance study of the interaction between acetylcholine and horse serum cholinesterase.
    Kato G
    Mol Pharmacol; 1969 Mar; 5(2):148-55. PubMed ID: 4306791
    [No Abstract]   [Full Text] [Related]  

  • 8. NMR studies on drug-receptor interactions. The binding of atropine and eserine to acetylcholinesterase.
    Kato G
    Int Z Klin Pharmakol Ther Toxikol; 1971 Aug; 5(1):12-9. PubMed ID: 4328180
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of membrane-bound acetylcholinesterase activity by bisquaternary nitrogen compounds.
    Wombacher H; Wolf HU
    Mol Pharmacol; 1971 Sep; 7(5):554-66. PubMed ID: 4257951
    [No Abstract]   [Full Text] [Related]  

  • 10. Internal flexibility of inhibitors bound to Electrophorus electricus acetylcholinesterase: proton nuclear magnetic resonance spectroscopy.
    Marshall AG; Carruthers JM
    Mol Pharmacol; 1981 Jul; 20(1):89-97. PubMed ID: 7290088
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase.
    Roufogalis BD; Quist EE
    Mol Pharmacol; 1972 Jan; 8(1):41-9. PubMed ID: 5062233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of the mechanism of action of choline, tetramethylammonium, gallamine, tetraethylammonium and calcium on the acetylcholinesterase of human erythrocyte membranes].
    Laget P; Chomel A; Pieri J
    Biochimie; 1974; 56(8):1119-27. PubMed ID: 4447809
    [No Abstract]   [Full Text] [Related]  

  • 13. On the question: is acetylcholinesterase an allosteric protein?
    Kitz RJ; Braswell LM; Ginsburg S
    Mol Pharmacol; 1970 Mar; 6(2):108-21. PubMed ID: 5418229
    [No Abstract]   [Full Text] [Related]  

  • 14. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand binding properties of acetylcholinesterase determined with fluorescent probes.
    Mooser G; Sigman DS
    Biochemistry; 1974 May; 13(11):2299-307. PubMed ID: 4857568
    [No Abstract]   [Full Text] [Related]  

  • 16. REVERSIBLE INHIBITION OF ELECTRIC-ORGAN CHOLINESTERASE BY CURARE AND CURARE-LIKE AGENTS.
    HASSON A; LIEPIN LL
    Biochim Biophys Acta; 1963 Nov; 75():397-401. PubMed ID: 14104949
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of tetraethylammonium ion on the reaction between acetylcholinesterase and selected inhibitors.
    Iverson F
    Mol Pharmacol; 1971 Mar; 7(2):129-35. PubMed ID: 5125850
    [No Abstract]   [Full Text] [Related]  

  • 18. Kinetics of inhibition of acetylcholinesterase in the presence of acetonitrile.
    Pietsch M; Christian L; Inhester T; Petzold S; Gütschow M
    FEBS J; 2009 Apr; 276(8):2292-307. PubMed ID: 19292865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.
    Elsinghorst PW; Cieslik JS; Mohr K; Tränkle C; Gütschow M
    J Med Chem; 2007 Nov; 50(23):5685-95. PubMed ID: 17944454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMR studies of the interaction of eserine and atropine with acetylchol inesterase.
    Kato G; Yung J; Ihnat M
    Biochem Biophys Res Commun; 1970 Jul; 40(1):15-21. PubMed ID: 4318583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.